AIDS: screening of possible carriers and human rights. NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS: screening of possible carriers and human rights.

Health Policy. 1987 Feb;7(1):13-9. Unique Identifier : AIDSLINE AHA/87108951
Gevers JK

Abstract: Like other serious infectious diseases, AIDS gives rise to a fundamental conflict between personal rights and public health. The recently developed test to detect antibody to the viral agent for AIDS is now predominantly being used to screen blood donors but it may spread to other settings. The possibility to demonstrate who is positive for the AIDS virus has raised a number of questions concerning the report-ability and confidentiality of test results; the right not to know and not to be informed about carrier status; the importance of informed consent as a requirement for testing; and the civil liberties of persons demonstrated to be seropositive. It is argued that public health policies should respect individual freedom and responsibility, not only because basic human rights are at stake, but also because such an approach is likely to be more effective in controlling the disease.
Keywords: Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL Blood Banks/STANDARDS *Civil Rights Confidentiality/LEGISLATION & JURISPRUD Europe Human Mass Screening/LEGISLATION & JURISPRUD Netherlands Public Health Administration/*STANDARDS JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDprevention&controlbloodbanks/standardsKWDcivilrightsconfidentiality/legislation&jurisprudeuropehumanmassscreening/legislation&jurisprudnetherlandspublichealthadministration/KWDstandardsjournalarticle
870530
M8750331

Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .